Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Background: Cohorts such as UK Biobank are increasingly used to study multimorbidity; however, there are concerns that lack of representativeness may lead to biased results. This study aims to compare associations between multimorbidity and adverse health outcomes in UK Biobank and a nationally representative sample. Methods and findings: These are observational analyses of cohorts identified from linked routine healthcare data from UK Biobank participants (n = 211,597 from England, Scotland, and Wales with linked primary care data, age 40 to 70, mean age 56.5 years, 54.6% women, baseline assessment 2006 to 2010) and from the Secure Anonymised Information Linkage (SAIL) databank (n = 852,055 from Wales, age 40 to 70, mean age 54.2, 50.0% women, baseline January 2011). Multimorbidity (n = 40 long-term conditions [LTCs]) was identified from primary care Read codes and quantified using a simple count and a weighted score. Individual LTCs and LTC combinations were also assessed. Associations with all-cause mortality, unscheduled hospitalisation, and major adverse cardiovascular events (MACEs) were assessed using Weibull or negative binomial models adjusted for age, sex, and socioeconomic status, over 7.5 years follow-up for both datasets. Multimorbidity was less common in UK Biobank than SAIL (26.9% and 33.0% with ≥2 LTCs in UK Biobank and SAIL, respectively). This difference was attenuated, but persisted, after standardising by age, sex, and socioeconomic status. The association between increasing multimorbidity count and mortality, hospitalisation, and MACE was similar between both datasets at LTC counts of ≤3; however, above this level, UK Biobank underestimated the risk associated with multimorbidity (e.g., mortality hazard ratio for 2 LTCs 1.62 (95% confidence interval 1.57 to 1.68) in SAIL and 1.51 (1.43 to 1.59) in UK Biobank, hazard ratio for 5 LTCs was 3.46 (3.31 to 3.61) in SAIL and 2.88 (2.63 to 3.15) in UK Biobank). Absolute risk of mortality, hospitalisation, and MACE, at all levels of multimorbidity, was lower in UK Biobank than SAIL (adjusting for age, sex, and socioeconomic status). Both cohorts produced similar hazard ratios for some LTCs (e.g., hypertension and coronary heart disease), but UK Biobank underestimated the risk for others (e.g., alcohol-related disorders or mental health conditions). Hazard ratios for some LTC combinations were similar between the cohorts (e.g., cardiovascular conditions); however, UK Biobank underestimated the risk for combinations including other conditions (e.g., mental health conditions). The main limitations are that SAIL databank represents only part of the UK (Wales only) and that in both cohorts we lacked data on severity of the LTCs included. Conclusions: In this study, we observed that UK Biobank accurately estimates relative risk of mortality, unscheduled hospitalisation, and MACE associated with LTC counts ≤3. However, for counts ≥4, and for some LTC combinations, estimates of magnitude of association from UK Biobank are likely to be conservative. Researchers should be mindful of these limitations of UK Biobank when conducting and interpreting analyses of multimorbidity. Nonetheless, the richness of data available in UK Biobank does offers opportunities to better understand multimorbidity, particularly where complementary data sources less susceptible to selection bias can be used to inform and qualify analyses of UK Biobank.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Barnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., & Guthrie, B. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60240-2 · Cited by 6,972 · cited 4×
“, asthma, constipation, pain, dyspepsia, migraine, epilepsy) were used to confirm if the condition were current (also according to definitions described by Barnett and colleagues) [26].”
MethodInfluentialFry, A., Littlejohns, T. J., Sudlow, C., Doherty, N., Adamska, L., Sprosen, T., Collins, R., & Allen, N. E. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx246 · Cited by 3,979 · cited 9×
“UK Biobank is a large cohort study of approximately 500,000 people recruited from across England, Scotland, and Wales.”
BackgroundInfluentialTriangulation in aetiological epidemiology
Lawlor, D. A., Tilling, K., & Davey Smith, G. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyw314 · Cited by 1,129 · cited 1×
“It will also be worth considering how routine healthcare data can be linked with other information resources or enhanced by collection of additional data to enable more mechanistic research for those with complex multimorbidity and those living in areas of high socioeconomic deprivation [33].”
BackgroundThe use of fractional polynomials to model continuous risk variables in epidemiology
Royston, P., Ambler, G., & Sauerbrei, W. (1999) · International Journal of Epidemiology · doi:10.1093/ije/28.5.964 · Cited by 1,066 · cited 1×
“5, 1, 2, and 3 recommended by Royston and colleagues) to model nonlinear relationships between age and Townsend score and LTC counts [28].”
BackgroundBatty, G. D., Gale, C. R., Kivimäki, M., Deary, I. J., & Bell, S. (2020) · BMJ · doi:10.1136/bmj.m131 · Cited by 635 · cited 11×
“UK Biobank is a large cohort study of approximately 500,000 people recruited from across England, Scotland, and Wales.”
BackgroundResultInfluentialUK Biobank: Current status and what it means for epidemiology
Allen, N., Sudlow, C., Downey, P., Peakman, T., Danesh, J., Elliott, P., Gallacher, J., Green, J., Matthews, P., Pell, J., et al. (2012) · Health Policy and Technology · doi:10.1016/j.hlpt.2012.07.003 · Cited by 521
Foster, H. M. E., Celis-Morales, C. A., Nicholl, B. I., Petermann-Rocha, F., Pell, J. P., Gill, J. M. R., O'Donnell, C. A., & Mair, F. S. (2018) · The Lancet Public Health · doi:10.1016/s2468-2667(18)30200-7 · Cited by 441
Self-citationPhysical activity, multimorbidity, and life expectancy: a UK Biobank longitudinal study
Chudasama, Y. V., Khunti, K. K., Zaccardi, F., Rowlands, A. V., Yates, T., Gillies, C. L., Davies, M. J., & Dhalwani, N. N. (2019) · BMC Medicine · doi:10.1186/s12916-019-1339-0 · Cited by 353
UK Biobank, big data, and the consequences of non-representativeness
Keyes, K. M., & Westreich, D. (2019) · The Lancet · doi:10.1016/s0140-6736(18)33067-8 · Cited by 187 · cited 1×
“Others, however, have questioned this assertion [22].”
Research works printed but not linked: 24
- CJ Whitty, 2020, Rising to the challenge of multimorbidity, BMJ, 368
- H Nguyen, 2019, Prevalence of multimorbidity in community settings: A systematic review and meta-analysis of observational studies, J Comorb, 9, 10.1177/2235042X19870934 · DOI · Paper page
- SH van Oostrom, 2016, Time trends in prevalence of chronic diseases and multimorbidity not only due to aging: data from general practices and health surveys, PLoS ONE, 11, e0160264, 10.1371/journal.pone.0160264 · DOI · Paper page
- BD Jani, 2019, Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort, BMC Med, 17, 74, 10.1186/s12916-019-1305-x · DOI · Paper page
- RA Payne, 2020, Development and validation of the Cambridge Multimorbidity Score, CMAJ, 192, E107, 10.1503/cmaj.190757 · DOI · Paper page
- DL Vetrano, 2020, Twelve-year clinical trajectories of multimorbidity in a population of older adults, Nat Commun, 11, 1, 10.1038/s41467-020-16780-x · DOI · Paper page
- Y Zhu, 2020, Characteristics, service use and mortality of clusters of multimorbid patients in England: a population-based study, BMC Med, 18, 1
- DT Zemedikun, 2018, editors. Patterns of multimorbidity in middle-aged and older adults: an analysis of the UK Biobank data, Mayo Clin Proc, 93, 857, 10.1016/j.mayocp.2018.02.012 · DOI · Paper page
- P Hanlon, 2018, Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants, Lancet Public Health, 3, e323, 10.1016/S2468-2667(18)30091-4 · DOI · Paper page
- RM Dodds, 2020, Sarcopenia, long-term conditions, and multimorbidity: findings from UK Biobank participants, J Cachexia Sarcopenia Muscle, 11, 62, 10.1002/jcsm.12503 · DOI · Paper page
- E Di Angelantonio, 2015, Association of cardiometabolic multimorbidity with mortality, JAMA, 314, 52, 10.1001/jama.2015.7008 · DOI · Paper page
- JI Chiang, 2020, Multimorbidity, mortality, and HbA1c in type 2 diabetes: A cohort study with UK and Taiwanese cohorts, PLoS Med, 17, e1003094, 10.1371/journal.pmed.1003094 · DOI
- P Hanlon, 2021, An analysis of frailty and multimorbidity in 20,566 UK Biobank participants with type 2 diabetes, Commun Med (London), 1, 1
- MK Sullivan, 2021, Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings, BMC Med, 19, 278, 10.1186/s12916-021-02147-6 · DOI
- TA Manolio, 2010, Enhancing the Feasibility of Large Cohort Studies, JAMA, 304, 2290, 10.1001/jama.2010.1686 · DOI · Paper page
- GJ Griffith, 2020, Collider bias undermines our understanding of COVID-19 disease risk and severity, Nat Commun, 11, 5749, 10.1038/s41467-020-19478-2 · DOI · Paper page
- C Infante-Rivard, 2018, Reflection on modern methods: selection bias—a review of recent developments, Int J Epidemiol, 47, 1714, 10.1093/ije/dyy138 · DOI
- KH Jones, 2019, A profile of the Sail Databank on the UK secure research platform, Int J Popul Data Sci, 4
- C Schnier, 2020, The secure Anonymised information linkage databank dementia e-cohort (SAIL-DeC), Int J Popul Data Sci, 5
- P Hanlon, 2019, Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis, BMC Med, 17, 201, 10.1186/s12916-019-1427-1 · DOI
- P Townsend, 1988, Health and deprivation: inequality and the North: Routledge
- F Yang, 2016, Socioeconomic status in relation to Parkinson’s disease risk and mortality: A population-based prospective study, Medicine, 95, 10.1097/MD.0000000000004337 · DOI
- P Hanlon, 2020, Identifying frailty in trials: an analysis of individual participant data from trials of novel pharmacological interventions, BMC Med, 18, 1, 10.1186/s12916-020-01752-1 · DOI
- P Hanlon, 2020, Association between childhood maltreatment and the prevalence and complexity of multimorbidity: A cross-sectional analysis of 157,357 UK Biobank participants, J Comorb, 10, 10.1177/2235042X10944344 · DOI
Metadata
- Authors
- Hanlon, P., Jani, B. D., Nicholl, B., Lewsey, J., McAllister, D. A., & Mair, F. S.
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2022-03-07
- Volume
- 19
- Issue
- 3
- Pages
- e1003931
- ISSN
- 1549-1676
- Cited by
- 73
- References
- 9
- Language
- en
- Funders
- Medical Research Council (MR/S021949/1)
- Wellcome Trust (201492/Z/16/Z)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies. https://app.cochat.ai/papers/10.1371/journal.pmed.1003931
- The paper
- Hanlon, P., Jani, B. D., Nicholl, B., Lewsey, J., McAllister, D. A., & Mair, F. S. (2022). Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1003931
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.